ARCHIVES

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

This article is from The Cancer Letter archive.

Vol. 02 No. 40 | October 1, 1976

Download PDF Visit The Full Archive

Related Articles

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

Working Group: Restructure NCI, Improve Review Process, Encourage Independence

July 14, 1995

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

Capitol Hill: Mammography Quality standards Act Reintroduced

April 18, 1997

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001